Archives

by in
Entry Author Date Location
Affymax, Takeda Win Approval of Anemia Drug to Challenge Amgen 03/27/12 San Francisco
CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs 03/02/12 San Francisco
Xconomist of the Week: Roger Perlmutter’s Parting Thoughts on Amgen 03/01/12 National
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects 02/06/12 National
Affymax Prepares to Mount Challenge to Amgen Anemia Drug Monopoly 01/25/12 San Francisco
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge 01/17/12 San Francisco
Five Myths You’ll Hear This Week at the JP Morgan Healthcare Conference 01/09/12 National
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Momenta, Baxter Team Up on Biosimilars 12/23/11 Boston
Millennium, Metamark, Amgen, & More Boston Life Sciences Headlines 12/23/11 Boston
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
MIT-Born Enumeral Advances Human-Based Method for Hunting Drugs 12/20/11 New York
Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs 12/19/11 National
Amgen CEO Kevin Sharer’s Report Card: C 12/19/11 National
Affymax Passes FDA Panel Scrutiny, Looks to Challenge Amgen Anemia Drug 12/07/11 San Francisco
Affymax Shares Climb As FDA Considers Wider Use for Anemia Drug 12/05/11 San Francisco
My Immunex Remembrance: Getting Scooped on the Biggest Biotech Story of 2001 11/18/11 Seattle
Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny 11/17/11 San Francisco
Biopharmaceuticals: Nothing Compares to You 11/17/11 National
The Immunex Impact: A Trivia Quiz 11/15/11 Seattle
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
Amgen Cuts 70 Washington Jobs, Hutch Spins Off Blaze Bioscience, Henney Enters the Hall, & More Seattle-Area Life Sciences News 10/20/11 Seattle
Amgen Confirms 380 Layoffs in R&D; Cuts Coming to Seattle, SF, Boston 10/19/11 National
Got Some Immunex Memorabilia in the Closet? Break it Out at the Immunex Impact Dec. 1 10/19/11 Seattle
NextBio Sees Growth in Next Market: Physicians Seeking Help Interpreting Individual Genomes 10/18/11 San Francisco
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News 10/13/11 Seattle
Amgen Looking to Improve Focus and “Re-allocate Resources” for R&D, Say More Oct. 24 10/12/11 National
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom 10/05/11 New York
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy 09/08/11 San Francisco
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead 09/06/11 National
Page 3 of 11 « previous page · next page »

Xconomy Events Across the Network

XSITE 2013: Boston’s Tech Revival

Boston · 6/19/13
9:00 am

More Xconomy Events

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Zillions of Biotech Conferences Want You. Which Should You Attend?
  4. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  5. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.